U.S. flag

An official website of the United States government

NM_000020.3(ACVRL1):c.760_762del (p.Asp254del) AND Cardiovascular phenotype

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Mar 2, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002390098.9

Allele description [Variation Report for NM_000020.3(ACVRL1):c.760_762del (p.Asp254del)]

NM_000020.3(ACVRL1):c.760_762del (p.Asp254del)

Gene:
ACVRL1:activin A receptor like type 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q13.13
Genomic location:
Preferred name:
NM_000020.3(ACVRL1):c.760_762del (p.Asp254del)
HGVS:
  • NC_000012.12:g.51914573_51914575del
  • NG_009549.1:g.12156_12158del
  • NM_000020.3:c.760_762delMANE SELECT
  • NM_001077401.2:c.760_762del
  • NP_000011.2:p.Asp254del
  • NP_001070869.1:p.Asp254del
  • LRG_543t1:c.760_762del
  • LRG_543:g.12156_12158del
  • NC_000012.11:g.52308355_52308357del
  • NC_000012.11:g.52308357_52308359del
  • NM_000020.2:c.760_762del
  • NM_000020.2:c.760_762delGAC
Protein change:
D254del
Links:
OMIM: 601284.0008; dbSNP: rs387906393
NCBI 1000 Genomes Browser:
rs387906393
Molecular consequence:
  • NM_000020.3:c.760_762del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001077401.2:c.760_762del - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002675267Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Mar 2, 2022)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, Nichols WC, Morrell NW, Berg J, Manes A, McGaughran J, Pauciulo M, Wheeler L.

N Engl J Med. 2001 Aug 2;345(5):325-34.

PubMed [citation]
PMID:
11484689

Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia.

Olivieri C, Mira E, Delù G, Pagella F, Zambelli A, Malvezzi L, Buscarini E, Danesino C.

J Med Genet. 2002 Jul;39(7):E39. No abstract available.

PubMed [citation]
PMID:
12114496
PMCID:
PMC1735165
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV002675267.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The c.760_762delGAC variant (also known as p.D254del) is located in coding exon 5 of the ACVRL1 gene. This variant results from an in-frame deletion of GAC between nucleotide positions 760 and 762. This results in the deletion of an aspartic acid residue at codon 254. In one study, this variant was detected in one HHT family and was found to segregate with disease (Trembath RC, et al. N. Engl. J. Med. 2001 Aug; 345(5):325-34). In addition, this variant was reported in an individual with epistaxis, telangiectasias, a hepatic ateriovenous malformation, and a family history of HHT (McDonald J, et al. Clin. Genet. 2011 Apr; 79(4):335-44). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024